
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical has demonstrated robust operational growth, evidenced by approximately 13% year-over-year procedure growth, which has now increased by 90 basis points mainly due to strong performance in the US market. The company also recorded a notable 35% year-over-year growth in da Vinci after-hours procedures, alongside a 3% increase in US utilization rates. Furthermore, the improved average selling prices (ASPs) for systems reflect the company's strong market position and increasing demand for its innovative robotic surgical solutions.
Bears say
The outlook on Intuitive Surgical's stock is negatively impacted by several key financial indicators, including anticipated downward pressure on average selling prices (ASPs) for both systems and instruments, largely influenced by a decline in bariatric procedures and an increase in cholecystectomy cases. Additionally, while the adoption of the da Vinci 5 (Dv5) system is pivotal for overall system growth, the contributions to instruments and accessories revenue appear less robust, highlighting a reliance on procedural growth that poses risks to revenue stability. Furthermore, slower-than-expected growth in international markets like Japan and challenges in capital placements signal a potentially more difficult environment for the company's financial performance moving forward.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares